Table 3. Genotypic frequencies of chemokine single nucleotide polymorphisms in patients and controls.

Genotype		Patients n=(141)	Controls n=(282)
MCP-1 -2518 A/G	AA	58.2%	53.4%
	AG	36.9%	38.5%
	GG	5.0%	8.1%
RANTES -403 G/A	GG	61.0%	63.3%
	GA	34.8%	31.8%
	AA	4.3%	4.9%
RANTES -28 C/G	CC	94.3%	94.3%
	CG	5.7%	5.3%
	GG	0.0%	0.4%
CCR2 V64I	VV	82.3%	87.2%
	VI	16.3%	12.5%
	II	1.4%	0.4%
CCR5 -59029 G/A	GG	21.3%	22.3%
	GA	44.7%	48.6%
	AA	34.0%	29.1%
CCR2 32 bp deletion	wt/wt	77.3%	76.6%
	wt/del	20.6%	21.6%
	del/del	2.1%	1.8%

The genotypic frequencies of the six polymorphisms were compared between patients and controls. The frequencies are shown in percentage and as seen in the table there are no significant differences between the genotypic frequencies of patients and controls.